Mitigation of atrial fibrillation‐related complications with antithrombotic and cytoreductive therapy in patients with Myeloproliferative Neoplasms: Implications from the GSG‐MPN bioregistry
Hyunyee Rosa Cho, Susanne Isfort, Kim Kricheldorf, Frank Stegelmann, Martine Klausmann, Florian H. Heidel, Martin Griesshammer, Holger Schulz, Andreas Hochhaus, Joachim Göthert, Rudolf Schlag, Wiebke Hollburg, Lino Teichmann, Katja Sockel, Stefan Wilop, Deniz Gezer
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMyeloproliferative Neoplasms: Diagnosis and Treatment · Eosinophilic Disorders and Syndromes · Chronic Myeloid Leukemia Treatments